CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

L. Vroling, J.S.W. Lind, R.R. de Haas, H.M.W. Verheul, V.W.M. van Hinsbergh, H.J. Broxterman, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

69 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)268-275
JournalBritish Journal of Cancer
Volume102
Issue number2
DOIs
Publication statusPublished - 2010

Cite this